Hundreds of coronavirus patients are pleading to join clinical trials of a US-made Ebola drug
Coronavirus patients from around the world are pleading to join studies of an experimental US antiviral drug that could help fight off the potentially deadly disease. Interest has been so great that the US National Institutes of Health (NIH) is expanding its study of remdesvir, which has nearly reached its initial goal of 440 patients. … Read more